On July 10, 2025, the ARPA-H Customer Experience Hub in Dallas hosted the Chronic Disease Awareness Day Healthcare & Biotech Leadership Summit, bringing together approximately 120 national and regional leaders from government, healthcare, biotechnology, and patient advocacy sectors. The summit, organized by the nonprofit Good Days, aimed to address pressing challenges faced by patient communities, explore strategies to enhance care accessibility, and advance equity within the healthcare system.
The event featured a diverse lineup of speakers, including Jenny Ligon, Ecosystem Liaison at the ARPA-H Customer Experience Hub; Clorinda Walley, President of Good Days; Sulagna Bhattacharya, President of Nanoscope Therapeutics; and Jen Peterson, Miss Texas for America Strong 2023 and a patient advocate. Their discussions centered on the importance of patient-centered innovation and the need for collaborative efforts to improve chronic disease prevention, treatment, and access to healthcare nationwide.
Chronic diseases remain a significant public health concern in the United States, accounting for seven of the top ten leading causes of death and contributing to more than 90% of the nation’s annual healthcare spending. The summit underscored the urgency of addressing these issues through coordinated efforts among stakeholders.
The ARPA-H Customer Experience Hub, a public-private partnership between the Advanced Research Projects Agency for Health (ARPA-H) and Advanced Technology International, served as an apt venue for the summit. The hub focuses on accelerating innovation in health and medicine through a human-centered approach, aiming to ensure that future healthcare advancements are patient-centric and deliver improved outcomes for all Americans.
The summit also highlighted the importance of federal initiatives and regional collaborations in driving progress. Participants discussed actionable opportunities to enhance chronic disease prevention, treatment, and healthcare access, emphasizing the role of policy advocacy and community engagement.
Chronic Disease Awareness Day, observed annually on July 10, serves as a reminder of the impact of chronic diseases and the importance of ongoing efforts to address them. The date was chosen to signify that seven out of ten deaths in the U.S. are due to chronic diseases. The day is marked by various events and campaigns aimed at raising awareness, promoting prevention, and advocating for better healthcare policies.
The summit in Dallas exemplified the collaborative spirit necessary to tackle the challenges posed by chronic diseases. By bringing together leaders from various sectors, the event fostered discussions that could lead to meaningful improvements in healthcare delivery and patient outcomes.
As the nation continues to grapple with the burden of chronic diseases, events like the Chronic Disease Awareness Day Healthcare & Biotech Leadership Summit play a crucial role in uniting stakeholders and driving forward the agenda for better health equity and access.
